Maetta Sciences announced that FDA clearance has been obtained for a cobalt chrome orthopaedic implantable device manufactured with its proprietary metal injection molding (MIM) technology. This project was developed in close collaboration with one of the company’s large OEM customers. The company will commence production of this device for market introduction this fall.
Maetta believes that this is the first time FDA clearance is obtained for an implantable device made by MIM. (Source: Maetta Sciences Inc.)
